Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Poster Presentations - Immune Response to Therapies

  • Abstract 6670: Combined signals from tumor and immune cells predict outcomes of checkpoint inhibition in melanoma
    Samuel S. Freeman, Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Arvind Ravi, Monica Arniella, Keren Yizhak, Ignaty Leshchiner, Liudmila Elagina, Oliver Spiro, Dimitri Livitz, Daniel Rosebrock, François Aguet, Jian Carrot-Zhang, Anna Gonye, Gavin Ha, Ziao Lin, Jonathan H. Chen, Dennie T. Frederick, Michal Barzily-Rokni, Marc R. Hammond, Hans Vitzthum, Shauna M. Blackmon, Yunxin J. Jiao, Donald P. Lawrence, Lyn M. Duncan, Anat Stemmer-Rachamimov, Jennifer A. Wargo, Keith T. Flaherty, Genevieve M. Boland, Ryan J. Sullivan, Matthew Meyerson, Gad Getz, Nir Hacohen
    Cancer Research Aug 2020, 80 (16 Supplement) 6670; DOI: 10.1158/1538-7445.AM2020-6670
  • Abstract 6674: Multi-dimensional time-series analysis to reveal pharmacodynamic changes induced by immunotherapy
    Jingjing Wang, Panpan Wang, Wenli Zhang, Qiyao Zhang, Qingyang Gu, Qunsheng Ji
    Cancer Research Aug 2020, 80 (16 Supplement) 6674; DOI: 10.1158/1538-7445.AM2020-6674
  • Abstract 6666: Evaluation of the complexity of the immune response to CMP-001, a TLR9 agonist
    Shakoora Sabree, Andrew Voigt, Laura Rogers, Sue Blackwell, Caitlin Lemke-Miltner, George J. Weiner
    Cancer Research Aug 2020, 80 (16 Supplement) 6666; DOI: 10.1158/1538-7445.AM2020-6666
  • Abstract 6684: Association of human leukocyte antigen (HLA) homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with PD-L1 inhibitors as frontline therapy
    Dongyup Lee, Jonghanne Park, Horyun Choi, Gahyun Gim, Sukjoo Cho, Leeseul Kim, Cyra Y. Kang, Pedro Viveiros, Young Kwang Chae
    Cancer Research Aug 2020, 80 (16 Supplement) 6684; DOI: 10.1158/1538-7445.AM2020-6684
  • Abstract 6655: Tumor microenvironment evaluation and tumor intrinsic genomic features predict anti-PD-1 response of metastatic gastric cancer: Results from phase II clinical trial and multi-omics data
    Dongqiang Zeng, Wangjun Liao, Kyoung Mee Kim, Min Shi, Rui Zhou, Yunfang Yu, Zilan Ye, Jiani Wu
    Cancer Research Aug 2020, 80 (16 Supplement) 6655; DOI: 10.1158/1538-7445.AM2020-6655
  • Abstract 6680: Inclusion of inhibitory neoantigens can abolish efficacy of otherwise protective therapeutic anti-tumor vaccines
    Victoria L. DeVault, Hanna Starobinets, Sanmit Adhikari, Simran Singh, Stephanie Rinaldi, Brendan Classon, Jessica B. Flechtner, Hubert Lam
    Cancer Research Aug 2020, 80 (16 Supplement) 6680; DOI: 10.1158/1538-7445.AM2020-6680
  • Abstract 6669: Cellular neighborhoods predict pembrolizumab response in cutaneous T cell lymphoma
    Christian M. Schürch, Darci J. Phillips, Belén Rivero Gutierrez, Magdalena Matusiak, Salil S. Bhate, Graham L. Barlow, Steven P. Fling, Nirasha Ramchurren, Robert H. Pierce, Martin A. Cheever, Michael S. Khodadoust, Robert West, Youn H. Kim, Garry P. Nolan
    Cancer Research Aug 2020, 80 (16 Supplement) 6669; DOI: 10.1158/1538-7445.AM2020-6669
  • Abstract 6659: Response to nivolumab and ipilimumab in microsatellite instability-high (MSI-H) cervical carcinoma with acquired resistance to pembrolizumab
    Gahyun Gim, Sukjoo Cho, Dongyup Lee, Jonghanne Park, Leeseul Kim, Horyun Choi, Cyra Y. Kang, Elena Vagia, Pedro Viveiros, Young Kwang Chae
    Cancer Research Aug 2020, 80 (16 Supplement) 6659; DOI: 10.1158/1538-7445.AM2020-6659
  • Abstract 6658: Deciphering anti-PDL1 effect in a syngeneic mouse model of sarcoma
    Imane Nafia, Assia Chaibi, Doriane Bortolotto, Christophe Rey, Antoine Italiano, Alban Bessede
    Cancer Research Aug 2020, 80 (16 Supplement) 6658; DOI: 10.1158/1538-7445.AM2020-6658
  • Abstract 6681: Inhibition of LSD1 using the reversible inhibitor SP2577 promotes Interferon dependent anti-tumor response in adrenocortical carcinoma
    Sunil Sharma, Raffaella Soldi, Alexis Weston, Samuel Sampson, Sherin Daniel Ampanattu, Scott Celinski, Haiyong Han, Mohan Kaadige, Michael Berens, Jeffrey Trent
    Cancer Research Aug 2020, 80 (16 Supplement) 6681; DOI: 10.1158/1538-7445.AM2020-6681

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement